Olivier Beuf1, Hélène Ratiney1, and Kevin Tse Ve Koon1
1CREATIS, CNRS, Inserm, INSA-Lyon, Universite Lyon 1, Lyon, France
Synopsis
Keywords: Image acquisition: Quantification, Neuro: Brain, Image acquisition: Multiparametric
In addition to the previous talks, this lecture is devoted to an overview of quantitative MRI methods in neuroimaging in the scope of personalized medicine. Advanced techniques such as MR elastography (MRE), chemical exchange saturation transfer (CEST), magnetic resonance spectroscopy (MRS), arterial spin labeling (ASL), dynamic contrast-enhanced (DCE) imaging, and X-nuclei imaging will be addressed. Measuring tissue stiffness, characterizing tissue content and organization, mapping metabolic state or assessing tissue perfusion are among information MRI can provide today. This comprehensive overview will highlight the potential of quantitative MRI in personalized healthcare for neurological disorders.
Abstract
Multi-parametric quantitative MRI methods
have emerged as powerful imaging techniques for a better understanding and
diagnosis of diseases, thus improving personalized medicine. This lecture
provides a structured panorama of key techniques, including magnetic resonance
elastography (MRE), chemical exchange saturation transfer (CEST), magnetic
resonance spectroscopy (MRS), arterial spin labeling (ASL), dynamic
contrast-enhanced (DCE) imaging, and X-nuclei imaging. The principle of each
technique is briefly described. The quantified parameters are discussed and their
relevance in the context of specific neurological pathologies are presented.
MRE is a non-invasive technique designed
to measure tissue stiffness and providing crucial insights into the mechanical
properties of the brain tissues. Applying external mechanical vibrations
synchronized with motion encoding gradients, the wave propagation can be
captured and then processed to quantify shear stiffness. This parameter has
proven to be valuable in neurodegenerative diseases, stroke, or traumatic brain
injuries, where alterations in tissue biomechanical properties appears (Streitberger, 2012). It is a potential biomarker of pathological changes (Bunevicius, 2020). MRE requires specific hardware and processing that
still need to be improved and standardized.
CEST imaging exploits the exchange of
protons between water and other molecules, offering a unique method to study
molecular dynamics. By selectively saturating the resonances of specific
compounds, such as proteins or metabolites, CEST enables the quantification of
their concentration and chemical exchange rates (Cai, 2012). This method
holds promise in characterizing tumors, as changes in cellular composition and
metabolism can be indicative of malignancy and personalized treatment
strategies guidance.
MRS provides insights into the biochemical
composition of tissues by measuring the resonance frequencies of specific
nuclei (Ladd, 2018). Commonly applied to study brain metabolites like
N-acetyl-aspartate, choline, and creatine, MRS allows for the quantification of
metabolite concentrations. In neuro-oncology, MRS aids in differentiating tumor
types and assessing treatment response, driving tailored therapeutic approaches
based on the metabolic profile of individual patients. Neurodegeneration and
neuroinflammation can also be characterized with MRS.
ASL is a perfusion imaging technique based
on the magnetic labeling of arterial blood as an endogenous contrast agent. By
quantifying cerebral blood flow (CBF), ASL provides critical information about
tissue perfusion (Alsop, 2015). This method proves valuable in
neurovascular diseases, such as ischemic stroke, where assessing regional
perfusion abnormalities aids in treatment decision-making, including the
identification of viable tissue for reperfusion therapy.
DCE imaging involves the administration of
contrast agents to assess tissue perfusion and microvascular permeability (Yablonskiy,
2013). By tracking dynamic distribution of the contrast agent, DCE imaging gives
access to blood volume and permeability. In neuro-oncology, DCE imaging aids in
tumor characterization, grading and monitoring treatment response helping in
driving therapeutic strategies based on vascular properties of individual
tumors.
X-nuclei imaging involves the utilization
of non-proton nuclei, such as sodium or phosphorus, for imaging purposes.
X-nuclei imaging provides information about cellular function, energy
metabolism, and ion homeostasis (Hu, 2020). In neurological disorders such
as multiple sclerosis, alterations in sodium concentration are indicative of
tissue inflammation and demyelination (Shah, 2016), making sodium imaging
a valuable tool for disease characterization and treatment monitoring.
Nevertheless, it is still limited to few centers equipped with specific
X-Nuclei chain.
In conclusion, the exploration of
multi-parametric quantitative MRI methods underscores their major role in
neuroimaging toward personalized medicine. Each technique offers unique
insights into different aspects of neurological pathophysiology, enabling
tailored approaches to diagnosis, prognosis and treatment. The integration of
these quantitative methods into clinical practice could change the management
of neurological disorders, paving the way to an era of truly personalized and
precision medicine.Acknowledgements
The work was performed within the framework of the LabEx PRIMES
(ANR-11-LABX-0063) and funded by ANR HERESP (ANR-22-CE19-0027) and PIONNER (ANR-22-CE19-0023) programs.
References
Alsop, D.C., Detre, J.A., Golay, X., Gu, M., Hendrikse, J.,
Hernandez-Garcia, L., Lu, H., MacIntosh, B.J., Parkes, L.M., Smits, M. et al.
(2015). Recommended implementation of arterial spin-labeled perfusion MRI for
clinical applications: A consensus of the ISMRM Perfusion Study Group and the
European Consortium for ASL in dementia. Magnetic Resonance in Medicine, 73,
102–116.
Bunevicius, A., Schregel, K., Sinkus, R., Golby, A., Patz, S. (2020).
Review: MR elastography of brain tumors. NeuroImage Clin., 25, 102109.
Cai, K., Haris, M., Singh, A., Kogan, F., Greenberg, J.H., Hariharan,
H., Detre, J.A., Reddy, R. (2012). Magnetic resonance imaging of glutamate. Nature
Medicine, 18(2), 302–306.
Hu, R., Kleimaier, D., Malzacher, M., Hoesl, M.A.U., Paschke, N.K.,
Schad, L.R. (2020). X-nuclei imaging: Current state, technical challenges, and
future directions. Journal of Magnetic Resonance Imaging, 51(2), 355–376.
Ladd, M.E., Bachert, P., Meyerspeer, M., Moser, E., Nagel, A.M., Norris,
D.G., Schmitter, S., Speck, O., Straub, S., Zaiss, M. (2018). Pros and cons of
ultra-high-field MRI/MRS for human application. Progress in Nuclear Magnetic
Resonance Spectroscopy, 109, 1–50.
Shah, N.J., Worthoff, W.A., Langen, K.J. (2016). Imaging of sodium in
the brain: A brief review. NMR in Biomedicine, 29(2), 162–174.
Streitberger, K.J., Sack, J., Krefting, D., Pfüller, C., Braun, J.,
Paul, F., Wuerfel, J. (2012). Brain viscoelasticity alteration in
chronic-progressive multiple sclerosis. PLoS One, 7(1),e29888.
Yablonskiy, D.A., Sukstanskii, A.L., He, X. (2013). Blood oxygenation
level-dependent (BOLD)-based techniques for the quantification of brain
hemodynamic and metabolic properties – Theoretical models and experimental
approaches: cerebral hemodynamics and metabolism. NMR in Biomedicine, 26(8),
963–986.